254 related articles for article (PubMed ID: 22419108)
1. GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)?
Dar MS; Chapman WH; Pender JR; Drake AJ; O'Brien K; Tanenberg RJ; Dohm GL; Pories WJ
Obes Surg; 2012 Jul; 22(7):1077-83. PubMed ID: 22419108
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.
Kashyap SR; Daud S; Kelly KR; Gastaldelli A; Win H; Brethauer S; Kirwan JP; Schauer PR
Int J Obes (Lond); 2010 Mar; 34(3):462-71. PubMed ID: 20029383
[TBL] [Abstract][Full Text] [Related]
4. Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
Nguyen KT; Billington CJ; Vella A; Wang Q; Ahmed L; Bantle JP; Bessler M; Connett JE; Inabnet WB; Thomas A; Ikramuddin S; Korner J
Diabetes; 2015 Sep; 64(9):3104-10. PubMed ID: 25901097
[TBL] [Abstract][Full Text] [Related]
5. Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass.
Jonsson I; Bojsen-Møller KN; Kristiansen VB; Veedfald S; Wewer Albrechtsen NJ; Clausen TR; Kuhre RE; Rehfeld JF; Holst JJ; Madsbad S; Svane MS
Front Endocrinol (Lausanne); 2021; 12():681116. PubMed ID: 34084153
[TBL] [Abstract][Full Text] [Related]
6. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
[TBL] [Abstract][Full Text] [Related]
7. Early improvement in glycemic control after bariatric surgery and its relationships with insulin, GLP-1, and glucagon secretion in type 2 diabetic patients.
Umeda LM; Silva EA; Carneiro G; Arasaki CH; Geloneze B; Zanella MT
Obes Surg; 2011 Jul; 21(7):896-901. PubMed ID: 21559794
[TBL] [Abstract][Full Text] [Related]
8. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
Jiménez A; Casamitjana R; Flores L; Delgado S; Lacy A; Vidal J
Ann Surg; 2013 May; 257(5):894-9. PubMed ID: 23579541
[TBL] [Abstract][Full Text] [Related]
9. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
[TBL] [Abstract][Full Text] [Related]
10. A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy.
Jirapinyo P; Jin DX; Qazi T; Mishra N; Thompson CC
Obes Surg; 2018 Mar; 28(3):615-626. PubMed ID: 28871519
[TBL] [Abstract][Full Text] [Related]
11. Does the hepatic branch of vagus mediate the secretion of glucagon-like peptide-1 during the Roux-en-Y gastric bypass surgery?
Qiu NC; Liu ME; Wang B; Song X; Jiang Y; Wang J; Gu ZQ; Shan CX; Qiu M
J Gastrointest Surg; 2014 Nov; 18(11):1957-64. PubMed ID: 25183408
[TBL] [Abstract][Full Text] [Related]
12. Similar Gut Hormone Secretions Two Years After One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Pilot Study.
De Bandt D; Rives-Lange C; Frigout Y; Bergerot D; Blanchard A; Le Gall M; Lacorte JM; Chevallier JM; Czernichow S; Poghosyan T; Carette C; Le Beyec J
Obes Surg; 2022 Mar; 32(3):757-762. PubMed ID: 34993850
[TBL] [Abstract][Full Text] [Related]
13. Investigating Intestinal Glucagon After Roux-en-Y Gastric Bypass Surgery.
Jorsal T; Wewer Albrechtsen NJ; Christensen MM; Mortensen B; Wandall E; Langholz E; Friis S; Worm D; Ørskov C; Støving RK; Andries A; Juhl CB; Sørensen F; Forman JL; Falkenhahn M; Musholt PB; Theis S; Larsen PJ; Holst JJ; Vrang N; Jelsing J; Vilsbøll T; Knop FK
J Clin Endocrinol Metab; 2019 Dec; 104(12):6403-6416. PubMed ID: 31276156
[TBL] [Abstract][Full Text] [Related]
14. Effects of Sleeve Gastrectomy and Gastric Bypass on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients: a 2-Year Follow-up.
Griffo E; Cotugno M; Nosso G; Saldalamacchia G; Mangione A; Angrisani L; Rivellese AA; Capaldo B
Obes Surg; 2016 Jun; 26(6):1247-53. PubMed ID: 26435537
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal Hormones and β-Cell Function After Gastric Bypass and Sleeve Gastrectomy: A Randomized Controlled Trial (Oseberg).
Fatima F; Hjelmesæth J; Birkeland KI; Gulseth HL; Hertel JK; Svanevik M; Sandbu R; Småstuen MC; Hartmann B; Holst JJ; Hofsø D
J Clin Endocrinol Metab; 2022 Jan; 107(2):e756-e766. PubMed ID: 34463768
[TBL] [Abstract][Full Text] [Related]
16. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.
Korner J; Bessler M; Inabnet W; Taveras C; Holst JJ
Surg Obes Relat Dis; 2007; 3(6):597-601. PubMed ID: 17936091
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Gastric Bypass with a Distal Gastric Pouch on Glucose Tolerance and Diabetes Remission in Type 2 Diabetes Sprague-Dawley Rat Model.
Dolo PR; Shao Y; Li C; Zhu X; Yao L; Wang H
Obes Surg; 2019 Jun; 29(6):1889-1900. PubMed ID: 30778846
[TBL] [Abstract][Full Text] [Related]
18. Effects of meal size on the release of GLP-1 and PYY after Roux-en-Y gastric bypass surgery in obese subjects with or without type 2 diabetes.
Yan W; Polidori D; Yieh L; Di J; Wu X; Moreno V; Li L; Briscoe CP; Shankley N; Dohm GL; Pories WJ
Obes Surg; 2014 Nov; 24(11):1969-74. PubMed ID: 24972682
[TBL] [Abstract][Full Text] [Related]
19. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.
Romero F; Nicolau J; Flores L; Casamitjana R; Ibarzabal A; Lacy A; Vidal J
Surg Endosc; 2012 Aug; 26(8):2231-9. PubMed ID: 22302537
[TBL] [Abstract][Full Text] [Related]
20. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.
Liu Y; Zhou Y; Wang Y; Geng D; Liu J
Obes Surg; 2011 Sep; 21(9):1424-31. PubMed ID: 21479766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
